Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 95 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 7919520

    Inhibitors of tace

    Vertex Pharmaceuticals Incorporated · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  2. US 7919513

    Inhibitors of p38

    Vertex Pharmaceuticals Incorporated · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  3. US 7919621

    Tricyclic inhibitors of 5-lipoxygenase

    AMIRA PHARMACEUTICALS, INC. · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  4. US 7915305

    Thiophene-carboxamides useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Mar 29, 2011 · Expires Mar 24, 2031

    granted

  5. US 7910587

    Quinoxalinyl dipeptide hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Mar 22, 2011 · Expires Mar 17, 2031

    granted

  6. US 7906513

    Hydrazide-containing hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Mar 15, 2011 · Expires Mar 10, 2031

    granted

  7. US 7906650

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Mar 15, 2011 · Expires Mar 10, 2031

    granted

  8. US 7906523

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Mar 15, 2011 · Expires Mar 10, 2031

    granted

  9. US 7906550

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Vertex Pharmaceuticals Incorporated · Granted Mar 15, 2011 · Expires Mar 10, 2031

    granted

  10. US 7906530

    1,7-naphthyridine derivatives as p38 MAP kinase inhibitors

    Laboratories Almirall, S.A. · Granted Mar 15, 2011 · Expires Mar 10, 2031

    granted

  11. US 7902239

    Diaminotriazoles useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Mar 8, 2011 · Expires Mar 3, 2031

    granted

  12. US 7902166

    Compositions comprising inhibitors of RNA binding proteins and methods of producing and using same

    The Board of Regents of the University of Oklahoma · Granted Mar 8, 2011 · Expires Mar 3, 2031

    granted

  13. US 7888357

    Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death

    Northwestern University · Granted Feb 15, 2011 · Expires Feb 10, 2031

    granted

  14. US 7888332

    Hydrazide-containing CFTR inhibitor compounds and uses thereof

    The Regents of the University of California · Granted Feb 15, 2011 · Expires Feb 10, 2031

    granted

  15. US 7884119

    Triazole derivatives useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Feb 8, 2011 · Expires Feb 3, 2031

    granted

  16. US 7883881

    Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes

    Vertex Pharmaceuticals Incorporated · Granted Feb 8, 2011 · Expires Feb 3, 2031

    granted

  17. US 7879891

    Caspase inhibitor prodrugs

    Vertex Pharmaceuticals Incorporated · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  18. US 7879856

    Diaminothiazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  19. US 7879792

    Synthetic peptide inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  20. US 7875712

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jan 25, 2011 · Expires Jan 20, 2031

    granted

  21. US 7872031

    c-MET protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jan 18, 2011 · Expires Jan 13, 2031

    granted

  22. US 7872124

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Jan 18, 2011 · Expires Jan 13, 2031

    granted

  23. US 7872000

    Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Jan 18, 2011 · Expires Jan 13, 2031

    granted

  24. US 7872129

    Compositions useful as inhibitors of GSK-3

    Vertex Pharmaceuticals Incorporated · Granted Jan 18, 2011 · Expires Jan 13, 2031

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.